Only 1 in 10 nonsurgical treatments for low back pain are more effective placebo, a review of 56 different treatments and ...

Novo Nordisk on Monday announced a $2 billion deal with a Chinese company making a drug in the same GLP-1 space where the ...

Novo Nordisk's hopes of heralding a new era of obesity treatment with its next-generation CagriSema drug may be in doubt ...

Since 2016, the FDA has approved three disease-modifying treatments for spinal muscular atrophy, with several ...

Available treatments for low back pain are plentiful, but there’s not good evidence that they really help, a new study finds ...

The issuer is solely responsible for the content of this announcement.

A new clinical trial has shown for the first time that taking high doses of vitamin D could stave off the progression of ...

Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the appointment of Adam Zaeske as Executive Vice President and Chief Commercial Officer (CCO), effective March 31, 2025. The ...

Shanghai Ark Biopharmaceutical Co., Ltd. ('ArkBio') today announced the successful completion of the Phase III clinical study ...

Gilead Sciences sees strong growth in HIV & oncology with BIKTARVY & TRODELVY. Learn about upcoming drugs & market potential ...

GABA supplements have gained popularity as a natural way to reduce anxiety, promote relaxation, and improve sleep quality.

The health benefits could be so extreme that it upends the annuity market, hitting retirement incomes and insurers ...